Obinutuzumab plus bendamustine in rituximab-refractory indolent lymphoma Journal Article

  

Author:	Hamlin, P. A.
Article Title:	Obinutuzumab plus bendamustine in rituximab-refractory indolent lymphoma
Journal Title:	Lancet Oncology
Volume:	17
Issue:	8
ISSN:	1470-2045
Publisher:	Elsevier Science, Inc.
Date Published:	2016-08-01
Start Page:	1023
End Page:	1025
Language:	English
DOI:	10.1016/s1470-2045(16)30157-7
PROVIDER:	scopus
PUBMED:	27345637
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977523282&partnerID=40&md5=062ebc16dd405585a23c0087d3aacd16
Notes:	Note -- Export Date: 6 December 2016 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/101505